New in the Hastings Center report, November-December 2017

November 30, 2017

Stemming the Standard-of-Care Sprawl: Clinician Self-Interest and the Case of Electronic Fetal Monitoring
Kayte Spector-Bagdady, Raymond De Vries, Lisa Hope Harris, and Lisa Kane Low

Continuous electronic fetal monitoring is often used during labor to monitor fetal heart rates, but in most pregnancies, the practice may increase risks to mother and baby. Despite strong evidence and professional guidelines that argue against the use of continuous EFM for healthy pregnancies, it persists as the standard of care. One of the main reasons for this is often assumed to be physicians' concerns about liability. This article examines if there are ways to ensure that the medical standard of care is based on the best interests of the patient, not on clinicians' concerns to protect against legal action. Spector-Bagdady is an assistant professor of obstetrics and gynecology, De Vries is the associate director of the Center for Bioethics and Social Sciences in Medicine, and Hope Harris is an associate professor of obstetrics and gynecology at the University of Michigan Medical School. Kane Low is an associate professor of health behavior and biological sciences at the University of Michigan School of Nursing.

Another Voice: Practices like continuous EFM may get "stuck" as the standard of care because the medical profession lacks a mechanism for ensuring that its members stay current with best practices. Instead, medical malpractice law is used to set the boundaries on acceptable practice. And as long as a respectable minority of doctors continue to embrace a given intervention, no matter its efficacy, the law will deem the practice reasonable, writes Michelle Oberman, a professor at Santa Clara University School of Law.

Ending DACA Has Pragmatic and Ethical Implications for U.S. Health Care
Danish Zaidi and Mark Kuczewski

In a letter to Congress earlier this year, the American Association of Medical Colleges wrote that the Deferred Action for Childhood Arrivals (DACA) program initiative would contribute more than 5,000 primary care physicians in the coming decades, many of whom would be positioned to care for underserved populations. This essay, coauthored by the director of medical education at the first U.S. medical school to recruit and accept students protected by DACA, outlines the serious practical and ethical consequences of the recent decision by the Trump administration to rescind the program. It highlights the urgent need for a sustainable solution to safeguard DACA recipients who would otherwise lose protections. Mark Kuczewski is the director of medical education at the Loyola University Chicago Stritch School of Medicine. Danish Zaidi is a doctor of medicine candidate at Wake Forest School of Medicine.

Perspective: "What's in a name?" CAR-T Gene Therapy
Eric Kodish

When Kodish served on the National Institutes of Health Recombinant DNA Advisory committee, he was repeatedly reminded not to speak of "gene therapy" but instead to use the term "gene transfer research." But in August, the FDA approved CAR-T gene therapy for relapsed childhood acute lymphoblastic leukemia, an intervention that holds great promise but can also cause life-threatening side effects. A pediatric hematologist at the Cleveland Clinic Lerner College of Medicine at Case Western Reserve University, Kodish asks if it is ever correct to speak of "therapeutic research" when the phrase may promote false hopes.
Also in this report:

Contact Susan Gilbert, director of communications
The Hastings Center
845-424-4040 x244

The Hastings Center

Related Gene Therapy Articles from Brightsurf:

Risk of AAV mobilization in gene therapy
New data highlight safety concerns for the replication of recombinant adeno-associated viral (rAAV) vectors commonly used in gene therapy.

Discovery challenges the foundations of gene therapy
An article published today in Science Translational Medicine by scientists from Children's Medical Research Institute has challenged one of the foundations of the gene therapy field and will help to improve strategies for treating serious genetic disorders of the liver.

Gene therapy: Novel targets come into view
Retinitis pigmentosa is the most prevalent form of congenital blindness.

Gene therapy targets inner retina to combat blindness
Batten disease is a group of fatal, inherited lysosomal storage disorders that predominantly affect children.

New Human Gene Therapy editorial: Concern following gene therapy adverse events
Response to the recent report of the deaths of two children receiving high doses of a gene therapy vector (AAV8) in a Phase I trial for X-linked myotubular myopathy (MTM).

Restoring vision by gene therapy
Latest scientific findings give hope for people with incurable retinal degeneration.

Gene therapy/gene editing combo could offer hope for some genetic disorders
A hybrid approach that combines elements of gene therapy with gene editing converted an experimental model of a rare genetic disease into a milder form, significantly enhancing survival, shows a multi-institutional study led by the University of Pennsylvania and Children's National Hospital in Washington, D.C.

New technology allows control of gene therapy doses
Scientists at Scripps Research in Jupiter have developed a special molecular switch that could be embedded into gene therapies to allow doctors to control dosing.

Gene therapy: Development of new DNA transporters
Scientists at the Institute of Pharmacy at Martin Luther University Halle-Wittenberg (MLU) have developed new delivery vehicles for future gene therapies.

Gene therapy promotes nerve regeneration
Researchers from the Netherlands Institute for Neuroscience and the Leiden University Medical Center have shown that treatment using gene therapy leads to a faster recovery after nerve damage.

Read More: Gene Therapy News and Gene Therapy Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to